The global Human Growth Hormone Drugs market size is projected to reach US$ 324.2 million by 2027, from US$ 253.9 million in 2020, at a CAGR of 4.2% during 2021-2027.
In terms of production side, this report researches the Human Growth Hormone Drugs production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Human Growth Hormone Drugs by regions (countries) and by Application.
The global Human Growth Hormone Drugs market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Human Growth Hormone Drugs market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Human Growth Hormone Drugs markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Human Growth Hormone Drugs market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Human Growth Hormone Drugs market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Human Growth Hormone Drugs market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Human Growth Hormone Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Human Growth Hormone Drugs market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Human Growth Hormone Drugs market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Human Growth Hormone Drugs market by each application segment for the same period.
This report includes the following manufacturers:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Market Segment by Type
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Market Segment by Application
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Research Methodology
To compile the detailed study of the global Human Growth Hormone Drugs market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Human Growth Hormone Drugs market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Human Growth Hormone Drugs market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Human Growth Hormone Drugs production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Human Growth Hormone Drugs by regions (countries) and by Application.
The global Human Growth Hormone Drugs market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Human Growth Hormone Drugs market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Human Growth Hormone Drugs markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Human Growth Hormone Drugs market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Human Growth Hormone Drugs market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Human Growth Hormone Drugs market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Human Growth Hormone Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Human Growth Hormone Drugs market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Human Growth Hormone Drugs market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Human Growth Hormone Drugs market by each application segment for the same period.
This report includes the following manufacturers:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Market Segment by Type
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Market Segment by Application
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Research Methodology
To compile the detailed study of the global Human Growth Hormone Drugs market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Human Growth Hormone Drugs market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Human Growth Hormone Drugs market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Type
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Market Segment by Application
1.3.1 Global Human Growth Hormone Drugs Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Human Growth Hormone Drugs Market Size (2016-2027)
2.1.1 Global Human Growth Hormone Drugs Revenue (2016-2027)
2.1.2 Global Human Growth Hormone Drugs Sales (2016-2027)
2.2 Global Human Growth Hormone Drugs Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Human Growth Hormone Drugs Sales by Regions (2016-2021)
2.2.2 Global Human Growth Hormone Drugs Revenue by Regions (2016-2021)
2.3 Global Human Growth Hormone Drugs Market Size Forecast by Region
2.3.1 Global Human Growth Hormone Drugs Sales Forecast by Region (2022-2027)
2.3.2 Global Human Growth Hormone Drugs Revenue Forecast by Region (2022-2027)
2.4 Global Top Human Growth Hormone Drugs Regions (Countries) Ranking by Market Size
2.5 Human Growth Hormone Drugs Industry Trends
2.5.1 Human Growth Hormone Drugs Market Trends
2.5.2 Human Growth Hormone Drugs Market Drivers
2.5.3 Human Growth Hormone Drugs Market Challenges
2.5.4 Human Growth Hormone Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Human Growth Hormone Drugs Manufacturers by Sales (2016-2021)
3.1.1 Global Human Growth Hormone Drugs Sales by Manufacturers (2016-2021)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Human Growth Hormone Drugs Sales in 2020
3.2 Global Top Manufacturers Human Growth Hormone Drugs by Revenue
3.2.1 Global Human Growth Hormone Drugs Revenue by Manufacturers (2016-2021)
3.2.2 Top Human Growth Hormone Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Human Growth Hormone Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Growth Hormone Drugs as of 2020)
3.4 Global Human Growth Hormone Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Human Growth Hormone Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Human Growth Hormone Drugs Market
3.7 Key Manufacturers Human Growth Hormone Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Human Growth Hormone Drugs Market Size by Type
4.1 Global Human Growth Hormone Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Human Growth Hormone Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Human Growth Hormone Drugs Price by Type (2016-2021)
4.2 Global Human Growth Hormone Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Growth Hormone Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Human Growth Hormone Drugs Price Forecast by Type (2022-2027)
5 Global Human Growth Hormone Drugs Market Size by Application
5.1 Global Human Growth Hormone Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Human Growth Hormone Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Human Growth Hormone Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Human Growth Hormone Drugs Price by Application (2016-2021)
5.2 Global Human Growth Hormone Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Growth Hormone Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Human Growth Hormone Drugs Price Forecast by Application (2022-2027)
6 North America
6.1 North America Human Growth Hormone Drugs Sales Breakdown by Company
6.1.1 North America Human Growth Hormone Drugs Sales by Company (2016-2027)
6.1.2 North America Human Growth Hormone Drugs Revenue by Company (2016-2027)
6.2 North America Human Growth Hormone Drugs Market Size by Type (2016-2027)
6.2.1 North America Human Growth Hormone Drugs Sales by Type (2016-2027)
6.2.2 North America Human Growth Hormone Drugs Revenue by Type (2016-2027)
6.3 North America Human Growth Hormone Drugs Market Size by Application (2016-2027)
6.3.1 North America Human Growth Hormone Drugs Sales by Application (2016-2027)
6.3.2 North America Human Growth Hormone Drugs Revenue by Application (2016-2027)
6.4 North America Human Growth Hormone Drugs Market Size by Country
6.4.1 North America Human Growth Hormone Drugs Sales by Country (2016-2027)
6.4.2 North America Human Growth Hormone Drugs Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Growth Hormone Drugs Sales Breakdown by Company
7.1.1 Europe Human Growth Hormone Drugs Sales by Company (2016-2027)
7.1.2 Europe Human Growth Hormone Drugs Revenue by Company (2016-2027)
7.2 Europe Human Growth Hormone Drugs Market Size by Type (2016-2027)
7.2.1 Europe Human Growth Hormone Drugs Sales by Type (2016-2027)
7.2.2 Europe Human Growth Hormone Drugs Revenue by Type (2016-2027)
7.3 Europe Human Growth Hormone Drugs Market Size by Application (2016-2027)
7.3.1 Europe Human Growth Hormone Drugs Sales by Application (2016-2027)
7.3.2 Europe Human Growth Hormone Drugs Revenue by Application (2016-2027)
7.4 Europe Human Growth Hormone Drugs Market Size by Country
7.4.1 Europe Human Growth Hormone Drugs Sales by Country (2016-2027)
7.4.2 Europe Human Growth Hormone Drugs Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Growth Hormone Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Human Growth Hormone Drugs Sales by Company (2016-2027)
8.1.2 Asia Pacific Human Growth Hormone Drugs Revenue by Company (2016-2027)
8.2 Asia Pacific Human Growth Hormone Drugs Market Size by Type (2016-2027)
8.2.1 Asia Pacific Human Growth Hormone Drugs Sales by Type (2016-2027)
8.2.2 Asia Pacific Human Growth Hormone Drugs Revenue by Type (2016-2027)
8.3 Asia Pacific Human Growth Hormone Drugs Market Size by Application (2016-2027)
8.3.1 Asia Pacific Human Growth Hormone Drugs Sales by Application (2016-2027)
8.3.2 Asia Pacific Human Growth Hormone Drugs Revenue by Application (2016-2027)
8.4 Asia Pacific Human Growth Hormone Drugs Market Size by Regions
8.4.1 Asia Pacific Human Growth Hormone Drugs Sales by Regions
8.4.2 Asia Pacific Human Growth Hormone Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Human Growth Hormone Drugs Sales Breakdown by Company
9.1.1 Latin America Human Growth Hormone Drugs Sales by Company (2016-2027)
9.1.2 Latin America Human Growth Hormone Drugs Revenue by Company (2016-2027)
9.2 Latin America Human Growth Hormone Drugs Market Size by Type (2016-2027)
9.2.1 Latin America Human Growth Hormone Drugs Sales by Type (2016-2027)
9.2.2 Latin America Human Growth Hormone Drugs Revenue by Type (2016-2027)
9.3 Latin America Human Growth Hormone Drugs Market Size by Application (2016-2027)
9.3.1 Latin America Human Growth Hormone Drugs Sales by Application (2016-2027)
9.3.2 Latin America Human Growth Hormone Drugs Revenue by Application (2016-2027)
9.4 Latin America Human Growth Hormone Drugs Market Size by Country
9.4.1 Latin America Human Growth Hormone Drugs Sales by Country (2016-2027)
9.4.2 Latin America Human Growth Hormone Drugs Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Growth Hormone Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Human Growth Hormone Drugs Sales by Company (2016-2027)
10.1.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Company (2016-2027)
10.2 Middle East and Africa Human Growth Hormone Drugs Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Human Growth Hormone Drugs Sales by Type (2016-2027)
10.2.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Type (2016-2027)
10.3 Middle East and Africa Human Growth Hormone Drugs Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Human Growth Hormone Drugs Sales by Application (2016-2027)
10.3.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Application (2016-2027)
10.4 Middle East and Africa Human Growth Hormone Drugs Market Size by Country
10.4.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country (2016-2027)
10.4.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Eli Lilly and Company (US)
11.1.1 Eli Lilly and Company (US) Corporation Information
11.1.2 Eli Lilly and Company (US) Overview
11.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products and Services
11.1.5 Eli Lilly and Company (US) Human Growth Hormone Drugs SWOT Analysis
11.1.6 Eli Lilly and Company (US) Recent Developments
11.2 Ferring Holding SA (Switzerland)
11.2.1 Ferring Holding SA (Switzerland) Corporation Information
11.2.2 Ferring Holding SA (Switzerland) Overview
11.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Products and Services
11.2.5 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs SWOT Analysis
11.2.6 Ferring Holding SA (Switzerland) Recent Developments
11.3 Genentech, Inc. (US)
11.3.1 Genentech, Inc. (US) Corporation Information
11.3.2 Genentech, Inc. (US) Overview
11.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Products and Services
11.3.5 Genentech, Inc. (US) Human Growth Hormone Drugs SWOT Analysis
11.3.6 Genentech, Inc. (US) Recent Developments
11.4 GeneScience Pharmaceuticals Co., Ltd. (China)
11.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
11.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Overview
11.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Products and Services
11.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs SWOT Analysis
11.4.6 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments
11.5 Merck KgaA (Germany)
11.5.1 Merck KgaA (Germany) Corporation Information
11.5.2 Merck KgaA (Germany) Overview
11.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Products and Services
11.5.5 Merck KgaA (Germany) Human Growth Hormone Drugs SWOT Analysis
11.5.6 Merck KgaA (Germany) Recent Developments
11.6 Novo Nordisk A/S (Denmark)
11.6.1 Novo Nordisk A/S (Denmark) Corporation Information
11.6.2 Novo Nordisk A/S (Denmark) Overview
11.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Products and Services
11.6.5 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs SWOT Analysis
11.6.6 Novo Nordisk A/S (Denmark) Recent Developments
11.7 Pfizer, Inc. (US)
11.7.1 Pfizer, Inc. (US) Corporation Information
11.7.2 Pfizer, Inc. (US) Overview
11.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Products and Services
11.7.5 Pfizer, Inc. (US) Human Growth Hormone Drugs SWOT Analysis
11.7.6 Pfizer, Inc. (US) Recent Developments
11.8 Sandoz International GmbH (Germany)
11.8.1 Sandoz International GmbH (Germany) Corporation Information
11.8.2 Sandoz International GmbH (Germany) Overview
11.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Products and Services
11.8.5 Sandoz International GmbH (Germany) Human Growth Hormone Drugs SWOT Analysis
11.8.6 Sandoz International GmbH (Germany) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Growth Hormone Drugs Value Chain Analysis
12.2 Human Growth Hormone Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Growth Hormone Drugs Production Mode & Process
12.4 Human Growth Hormone Drugs Sales and Marketing
12.4.1 Human Growth Hormone Drugs Sales Channels
12.4.2 Human Growth Hormone Drugs Distributors
12.5 Human Growth Hormone Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Type
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Market Segment by Application
1.3.1 Global Human Growth Hormone Drugs Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Human Growth Hormone Drugs Market Size (2016-2027)
2.1.1 Global Human Growth Hormone Drugs Revenue (2016-2027)
2.1.2 Global Human Growth Hormone Drugs Sales (2016-2027)
2.2 Global Human Growth Hormone Drugs Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Human Growth Hormone Drugs Sales by Regions (2016-2021)
2.2.2 Global Human Growth Hormone Drugs Revenue by Regions (2016-2021)
2.3 Global Human Growth Hormone Drugs Market Size Forecast by Region
2.3.1 Global Human Growth Hormone Drugs Sales Forecast by Region (2022-2027)
2.3.2 Global Human Growth Hormone Drugs Revenue Forecast by Region (2022-2027)
2.4 Global Top Human Growth Hormone Drugs Regions (Countries) Ranking by Market Size
2.5 Human Growth Hormone Drugs Industry Trends
2.5.1 Human Growth Hormone Drugs Market Trends
2.5.2 Human Growth Hormone Drugs Market Drivers
2.5.3 Human Growth Hormone Drugs Market Challenges
2.5.4 Human Growth Hormone Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Human Growth Hormone Drugs Manufacturers by Sales (2016-2021)
3.1.1 Global Human Growth Hormone Drugs Sales by Manufacturers (2016-2021)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Human Growth Hormone Drugs Sales in 2020
3.2 Global Top Manufacturers Human Growth Hormone Drugs by Revenue
3.2.1 Global Human Growth Hormone Drugs Revenue by Manufacturers (2016-2021)
3.2.2 Top Human Growth Hormone Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Human Growth Hormone Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Growth Hormone Drugs as of 2020)
3.4 Global Human Growth Hormone Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Human Growth Hormone Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Human Growth Hormone Drugs Market
3.7 Key Manufacturers Human Growth Hormone Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Human Growth Hormone Drugs Market Size by Type
4.1 Global Human Growth Hormone Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Human Growth Hormone Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Human Growth Hormone Drugs Price by Type (2016-2021)
4.2 Global Human Growth Hormone Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Growth Hormone Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Human Growth Hormone Drugs Price Forecast by Type (2022-2027)
5 Global Human Growth Hormone Drugs Market Size by Application
5.1 Global Human Growth Hormone Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Human Growth Hormone Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Human Growth Hormone Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Human Growth Hormone Drugs Price by Application (2016-2021)
5.2 Global Human Growth Hormone Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Growth Hormone Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Human Growth Hormone Drugs Price Forecast by Application (2022-2027)
6 North America
6.1 North America Human Growth Hormone Drugs Sales Breakdown by Company
6.1.1 North America Human Growth Hormone Drugs Sales by Company (2016-2027)
6.1.2 North America Human Growth Hormone Drugs Revenue by Company (2016-2027)
6.2 North America Human Growth Hormone Drugs Market Size by Type (2016-2027)
6.2.1 North America Human Growth Hormone Drugs Sales by Type (2016-2027)
6.2.2 North America Human Growth Hormone Drugs Revenue by Type (2016-2027)
6.3 North America Human Growth Hormone Drugs Market Size by Application (2016-2027)
6.3.1 North America Human Growth Hormone Drugs Sales by Application (2016-2027)
6.3.2 North America Human Growth Hormone Drugs Revenue by Application (2016-2027)
6.4 North America Human Growth Hormone Drugs Market Size by Country
6.4.1 North America Human Growth Hormone Drugs Sales by Country (2016-2027)
6.4.2 North America Human Growth Hormone Drugs Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Growth Hormone Drugs Sales Breakdown by Company
7.1.1 Europe Human Growth Hormone Drugs Sales by Company (2016-2027)
7.1.2 Europe Human Growth Hormone Drugs Revenue by Company (2016-2027)
7.2 Europe Human Growth Hormone Drugs Market Size by Type (2016-2027)
7.2.1 Europe Human Growth Hormone Drugs Sales by Type (2016-2027)
7.2.2 Europe Human Growth Hormone Drugs Revenue by Type (2016-2027)
7.3 Europe Human Growth Hormone Drugs Market Size by Application (2016-2027)
7.3.1 Europe Human Growth Hormone Drugs Sales by Application (2016-2027)
7.3.2 Europe Human Growth Hormone Drugs Revenue by Application (2016-2027)
7.4 Europe Human Growth Hormone Drugs Market Size by Country
7.4.1 Europe Human Growth Hormone Drugs Sales by Country (2016-2027)
7.4.2 Europe Human Growth Hormone Drugs Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Growth Hormone Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Human Growth Hormone Drugs Sales by Company (2016-2027)
8.1.2 Asia Pacific Human Growth Hormone Drugs Revenue by Company (2016-2027)
8.2 Asia Pacific Human Growth Hormone Drugs Market Size by Type (2016-2027)
8.2.1 Asia Pacific Human Growth Hormone Drugs Sales by Type (2016-2027)
8.2.2 Asia Pacific Human Growth Hormone Drugs Revenue by Type (2016-2027)
8.3 Asia Pacific Human Growth Hormone Drugs Market Size by Application (2016-2027)
8.3.1 Asia Pacific Human Growth Hormone Drugs Sales by Application (2016-2027)
8.3.2 Asia Pacific Human Growth Hormone Drugs Revenue by Application (2016-2027)
8.4 Asia Pacific Human Growth Hormone Drugs Market Size by Regions
8.4.1 Asia Pacific Human Growth Hormone Drugs Sales by Regions
8.4.2 Asia Pacific Human Growth Hormone Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Human Growth Hormone Drugs Sales Breakdown by Company
9.1.1 Latin America Human Growth Hormone Drugs Sales by Company (2016-2027)
9.1.2 Latin America Human Growth Hormone Drugs Revenue by Company (2016-2027)
9.2 Latin America Human Growth Hormone Drugs Market Size by Type (2016-2027)
9.2.1 Latin America Human Growth Hormone Drugs Sales by Type (2016-2027)
9.2.2 Latin America Human Growth Hormone Drugs Revenue by Type (2016-2027)
9.3 Latin America Human Growth Hormone Drugs Market Size by Application (2016-2027)
9.3.1 Latin America Human Growth Hormone Drugs Sales by Application (2016-2027)
9.3.2 Latin America Human Growth Hormone Drugs Revenue by Application (2016-2027)
9.4 Latin America Human Growth Hormone Drugs Market Size by Country
9.4.1 Latin America Human Growth Hormone Drugs Sales by Country (2016-2027)
9.4.2 Latin America Human Growth Hormone Drugs Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Growth Hormone Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Human Growth Hormone Drugs Sales by Company (2016-2027)
10.1.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Company (2016-2027)
10.2 Middle East and Africa Human Growth Hormone Drugs Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Human Growth Hormone Drugs Sales by Type (2016-2027)
10.2.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Type (2016-2027)
10.3 Middle East and Africa Human Growth Hormone Drugs Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Human Growth Hormone Drugs Sales by Application (2016-2027)
10.3.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Application (2016-2027)
10.4 Middle East and Africa Human Growth Hormone Drugs Market Size by Country
10.4.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country (2016-2027)
10.4.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Eli Lilly and Company (US)
11.1.1 Eli Lilly and Company (US) Corporation Information
11.1.2 Eli Lilly and Company (US) Overview
11.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products and Services
11.1.5 Eli Lilly and Company (US) Human Growth Hormone Drugs SWOT Analysis
11.1.6 Eli Lilly and Company (US) Recent Developments
11.2 Ferring Holding SA (Switzerland)
11.2.1 Ferring Holding SA (Switzerland) Corporation Information
11.2.2 Ferring Holding SA (Switzerland) Overview
11.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Products and Services
11.2.5 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs SWOT Analysis
11.2.6 Ferring Holding SA (Switzerland) Recent Developments
11.3 Genentech, Inc. (US)
11.3.1 Genentech, Inc. (US) Corporation Information
11.3.2 Genentech, Inc. (US) Overview
11.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Products and Services
11.3.5 Genentech, Inc. (US) Human Growth Hormone Drugs SWOT Analysis
11.3.6 Genentech, Inc. (US) Recent Developments
11.4 GeneScience Pharmaceuticals Co., Ltd. (China)
11.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
11.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Overview
11.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Products and Services
11.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs SWOT Analysis
11.4.6 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments
11.5 Merck KgaA (Germany)
11.5.1 Merck KgaA (Germany) Corporation Information
11.5.2 Merck KgaA (Germany) Overview
11.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Products and Services
11.5.5 Merck KgaA (Germany) Human Growth Hormone Drugs SWOT Analysis
11.5.6 Merck KgaA (Germany) Recent Developments
11.6 Novo Nordisk A/S (Denmark)
11.6.1 Novo Nordisk A/S (Denmark) Corporation Information
11.6.2 Novo Nordisk A/S (Denmark) Overview
11.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Products and Services
11.6.5 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs SWOT Analysis
11.6.6 Novo Nordisk A/S (Denmark) Recent Developments
11.7 Pfizer, Inc. (US)
11.7.1 Pfizer, Inc. (US) Corporation Information
11.7.2 Pfizer, Inc. (US) Overview
11.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Products and Services
11.7.5 Pfizer, Inc. (US) Human Growth Hormone Drugs SWOT Analysis
11.7.6 Pfizer, Inc. (US) Recent Developments
11.8 Sandoz International GmbH (Germany)
11.8.1 Sandoz International GmbH (Germany) Corporation Information
11.8.2 Sandoz International GmbH (Germany) Overview
11.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Products and Services
11.8.5 Sandoz International GmbH (Germany) Human Growth Hormone Drugs SWOT Analysis
11.8.6 Sandoz International GmbH (Germany) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Growth Hormone Drugs Value Chain Analysis
12.2 Human Growth Hormone Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Growth Hormone Drugs Production Mode & Process
12.4 Human Growth Hormone Drugs Sales and Marketing
12.4.1 Human Growth Hormone Drugs Sales Channels
12.4.2 Human Growth Hormone Drugs Distributors
12.5 Human Growth Hormone Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
